Roivant Sciences Ltd. - ROIV
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 02, 2026 | CEO | F | D | 76,171.0 | 35.39 | 2,695,691.69 | 16,659,945.0 | View | |
| Jul 02, 2026 | — | M | D | 10,000.0 | 0.0 | 0.0 | 38,578.0 | View | |
| Jul 02, 2026 | — | S | D | 10,000.0 | 34.9 | 349,000.0 | 42,963.0 | View | |
| Jul 02, 2026 | — | M | A | 10,000.0 | 8.8 | 88,000.0 | 52,963.0 | View | |
| Jul 02, 2026 | President and Vant Chair | F | D | 40,310.0 | 35.39 | 1,426,570.9 | 13,536,202.0 | View | |
| Jul 02, 2026 | President & CIO | F | D | 46,878.0 | 35.39 | 1,659,012.42 | 18,630,739.0 | View | |
| Jul 01, 2026 | — | M | D | 17,750.0 | 0.0 | 0.0 | 169,166.0 | View | |
| Jul 01, 2026 | — | S | D | 2,748.0 | 34.71 | 95,383.08 | 16,474.0 | View | |
| Jul 01, 2026 | — | S | D | 15,002.0 | 34.32 | 514,868.64 | 19,222.0 | View | |
| Jul 01, 2026 | — | M | A | 17,750.0 | 4.46 | 79,165.0 | 34,224.0 | View | |
| Jun 30, 2026 | — | S | D | 200,000.0 | 35.45 | 7,090,000.0 | 1,748,403.0 | View | |
| Jun 30, 2026 | — | S | D | 12,380.0 | 35.28 | 436,766.4 | 13,689,166.0 | View | |
| Jun 30, 2026 | — | S | D | 600,000.0 | 34.59 | 20,754,000.0 | 13,701,546.0 | View | |
| Jun 30, 2026 | — | S | D | 200,000.0 | 34.44 | 6,888,000.0 | 14,301,546.0 | View | |
| Jun 30, 2026 | — | S | D | 325,000.0 | 34.07 | 11,072,750.0 | 14,501,546.0 | View | |
| Jun 30, 2026 | — | S | D | 300,783.0 | 33.92 | 10,202,559.36 | 14,826,546.0 | View | |
| Jun 30, 2026 | — | S | D | 12,380.0 | 35.28 | 436,766.4 | 13,689,166.0 | View | |
| Jun 30, 2026 | — | S | D | 600,000.0 | 34.59 | 20,754,000.0 | 13,701,546.0 | View | |
| Jun 30, 2026 | — | S | D | 200,000.0 | 34.44 | 6,888,000.0 | 14,301,546.0 | View | |
| Jun 30, 2026 | — | S | D | 325,000.0 | 34.07 | 11,072,750.0 | 14,501,546.0 | View | |
| Jun 30, 2026 | — | S | D | 300,783.0 | 33.92 | 10,202,559.36 | 14,826,546.0 | View | |
| Jun 30, 2026 | — | S | D | 12,380.0 | 35.28 | 436,766.4 | 13,689,166.0 | View | |
| Jun 30, 2026 | — | S | D | 600,000.0 | 34.59 | 20,754,000.0 | 13,701,546.0 | View | |
| Jun 30, 2026 | — | S | D | 200,000.0 | 34.44 | 6,888,000.0 | 14,301,546.0 | View | |
| Jun 30, 2026 | — | S | D | 325,000.0 | 34.07 | 11,072,750.0 | 14,501,546.0 | View | |
| Jun 30, 2026 | — | S | D | 300,783.0 | 33.92 | 10,202,559.36 | 14,826,546.0 | View | |
| Jun 29, 2026 | President & CIO | M | D | 500,000.0 | 0.0 | 0.0 | 14,224,363.0 | View | |
| Jun 29, 2026 | President & CIO | M | D | 500,000.0 | 0.0 | 0.0 | 14,724,363.0 | View | |
| Jun 29, 2026 | President & CIO | S | D | 500,000.0 | 34.08 | 17,040,000.0 | 18,677,617.0 | View | |
| Jun 29, 2026 | President & CIO | M | A | 500,000.0 | 3.85 | 1,925,000.0 | 19,177,617.0 | View | |
| Jun 29, 2026 | President & CIO | S | D | 500,000.0 | 34.13 | 17,065,000.0 | 18,677,617.0 | View | |
| Jun 29, 2026 | President & CIO | M | A | 500,000.0 | 3.85 | 1,925,000.0 | 19,177,617.0 | View | |
| Jun 26, 2026 | President & Immunovant CEO | M | D | 200,000.0 | 0.0 | 0.0 | 4,244,834.0 | View | |
| Jun 26, 2026 | President & Immunovant CEO | S | D | 46,234.0 | 33.51 | 1,549,301.34 | 1,613,063.0 | View | |
| Jun 26, 2026 | President & Immunovant CEO | S | D | 153,766.0 | 33.05 | 5,081,966.3 | 1,659,297.0 | View | |
| Jun 26, 2026 | President & Immunovant CEO | M | A | 200,000.0 | 3.85 | 770,000.0 | 1,813,063.0 | View | |
| Jun 23, 2026 | CFO | F | D | 2,129.0 | 31.43 | 66,914.47 | 276,420.0 | View | |
| Jun 23, 2026 | Chief Accounting Officer | F | D | 3,582.0 | 31.43 | 112,582.26 | 109,782.0 | View | |
| May 22, 2026 | President & Immunovant CEO | M | D | 200,000.0 | 0.0 | 0.0 | 4,444,834.0 | View | |
| May 22, 2026 | President & Immunovant CEO | S | D | 200,000.0 | 30.27 | 6,054,000.0 | 1,613,063.0 | View | |
| May 22, 2026 | President & Immunovant CEO | M | A | 200,000.0 | 3.85 | 770,000.0 | 1,813,063.0 | View | |
| May 22, 2026 | President & Immunovant CEO | F | D | 34,483.0 | 32.41 | 1,117,594.03 | 1,613,063.0 | View | |
| May 22, 2026 | CFO | F | D | 18,962.0 | 32.41 | 614,558.42 | 278,549.0 | View | |
| Apr 22, 2026 | President & Immunovant CEO | M | D | 200,000.0 | 0.0 | 0.0 | 4,644,834.0 | View | |
| Apr 22, 2026 | President & Immunovant CEO | S | D | 200,000.0 | 29.59 | 5,918,000.0 | 1,647,546.0 | View | |
| Apr 22, 2026 | President & Immunovant CEO | M | A | 200,000.0 | 3.85 | 770,000.0 | 1,847,546.0 | View | |
| Apr 22, 2026 | CFO | A | A | 84,026.0 | 0.0 | 0.0 | 84,026.0 | View | |
| Apr 22, 2026 | CFO | A | A | 60,644.0 | 0.0 | 0.0 | 297,511.0 | View | |
| Apr 22, 2026 | Chief Accounting Officer | A | A | 27,157.0 | 0.0 | 0.0 | 27,157.0 | View | |
| Apr 22, 2026 | Chief Accounting Officer | A | A | 29,173.0 | 0.0 | 0.0 | 113,364.0 | View | |
| Apr 21, 2026 | — | F | D | 95.0 | 29.83 | 2,833.85 | 120,229.0 | View | |
| Apr 21, 2026 | — | A | A | 896.0 | 0.0 | 0.0 | 120,324.0 | View | |
| Apr 21, 2026 | — | A | A | 670.0 | 0.0 | 0.0 | 16,474.0 | View | |
| Apr 21, 2026 | — | F | D | 94.0 | 29.83 | 2,804.02 | 109,405.0 | View | |
| Apr 21, 2026 | — | A | A | 469.0 | 0.0 | 0.0 | 109,499.0 | View | |
| Apr 20, 2026 | CEO | S | D | 289,774.0 | 29.16 | 8,449,809.84 | 16,736,116.0 | View | |
| Apr 10, 2026 | Chief Accounting Officer | S | D | 13,538.0 | 28.37 | 384,073.06 | 84,191.0 | View | |
| Apr 02, 2026 | President and Vant Chair | F | D | 160,035.0 | 27.7 | 4,432,969.5 | 13,576,512.0 | View | |
| Apr 01, 2026 | CEO | M | D | 2,178,150.0 | 11.5 | 25,048,725.0 | 0.0 | View | |
| Apr 01, 2026 | CEO | F | D | 304,684.0 | 27.7 | 8,439,746.8 | 17,025,890.0 | View | |
| Apr 01, 2026 | CEO | F | D | 53,826.0 | 26.41 | 1,421,544.66 | 17,330,574.0 | View | |
| Apr 01, 2026 | CEO | M | A | 97,319.0 | — | — | 17,384,400.0 | View | |
| Apr 01, 2026 | President & CIO | M | D | 1,306,889.0 | 11.5 | 15,029,223.5 | 0.0 | View | |
| Apr 01, 2026 | President & CIO | F | D | 187,512.0 | 27.7 | 5,194,082.4 | 18,677,617.0 | View | |
| Apr 01, 2026 | President & CIO | F | D | 29,809.0 | 26.41 | 787,255.69 | 18,865,129.0 | View | |
| Apr 01, 2026 | President & CIO | M | A | 58,391.0 | — | — | 18,894,938.0 | View | |
| Mar 30, 2026 | — | M | D | 70,000.0 | 0.0 | 0.0 | 48,578.0 | View | |
| Mar 30, 2026 | — | S | D | 70,000.0 | 27.45 | 1,921,500.0 | 42,963.0 | View | |
| Mar 30, 2026 | — | M | A | 70,000.0 | 8.8 | 616,000.0 | 112,963.0 | View | |
| Mar 24, 2026 | CFO | F | D | 1,546.0 | 27.7 | 42,824.2 | 236,867.0 | View | |
| Mar 24, 2026 | Chief Accounting Officer | F | D | 14,526.0 | 27.7 | 402,370.2 | 97,729.0 | View | |
| Mar 19, 2026 | President & Immunovant CEO | M | D | 200,000.0 | 0.0 | 0.0 | 4,844,834.0 | View | |
| Mar 19, 2026 | President & Immunovant CEO | S | D | 200,000.0 | 28.24 | 5,648,000.0 | 1,647,546.0 | View | |
| Mar 19, 2026 | President & Immunovant CEO | M | A | 200,000.0 | 3.85 | 770,000.0 | 1,847,546.0 | View | |
| Mar 18, 2026 | — | S | D | 41,861.0 | 28.68 | 1,200,573.48 | 15,804.0 | View | |
| Feb 24, 2026 | CFO | F | D | 1,000.0 | 27.15 | 27,150.0 | 238,413.0 | View | |
| Feb 24, 2026 | President & Immunovant CEO | F | D | 7,051.0 | 27.15 | 191,434.65 | 1,647,546.0 | View | |
| Feb 23, 2026 | President and Vant Chair | M | D | 587,390.0 | 0.0 | 0.0 | 3,026,184.0 | View | |
| Feb 23, 2026 | President and Vant Chair | M | D | 1,012,610.0 | 0.0 | 0.0 | 3,613,574.0 | View | |
| Feb 23, 2026 | President and Vant Chair | M | D | 1,400,000.0 | 0.0 | 0.0 | 4,626,184.0 | View | |
| Feb 23, 2026 | President and Vant Chair | S | D | 587,390.0 | 27.51 | 16,159,098.9 | 13,736,547.0 | View | |
| Feb 23, 2026 | President and Vant Chair | M | A | 587,390.0 | 3.85 | 2,261,451.5 | 14,323,937.0 | View | |
| Feb 23, 2026 | President and Vant Chair | S | D | 1,012,610.0 | 27.15 | 27,492,361.5 | 13,736,547.0 | View | |
| Feb 23, 2026 | President and Vant Chair | M | A | 1,012,610.0 | 3.85 | 3,898,548.5 | 14,749,157.0 | View | |
| Feb 23, 2026 | President and Vant Chair | S | D | 1,400,000.0 | 27.42 | 38,388,000.0 | 13,736,547.0 | View | |
| Feb 23, 2026 | President and Vant Chair | M | A | 1,400,000.0 | 3.85 | 5,390,000.0 | 15,136,547.0 | View | |
| Feb 18, 2026 | President & Immunovant CEO | M | D | 200,000.0 | 0.0 | 0.0 | 5,044,834.0 | View | |
| Feb 18, 2026 | President & Immunovant CEO | S | D | 200,000.0 | 26.49 | 5,298,000.0 | 1,654,597.0 | View | |
| Feb 18, 2026 | President & Immunovant CEO | M | A | 200,000.0 | 3.85 | 770,000.0 | 1,854,597.0 | View | |
| Feb 13, 2026 | — | S | D | 225,000.0 | 26.5 | 5,962,500.0 | 15,127,329.0 | View | |
| Feb 13, 2026 | — | S | D | 150,784.0 | 26.49 | 3,994,268.16 | 15,352,329.0 | View | |
| Feb 13, 2026 | — | S | D | 275,000.0 | 26.76 | 7,359,000.0 | 15,503,113.0 | View | |
| Feb 13, 2026 | — | S | D | 150,000.0 | 26.72 | 4,008,000.0 | 15,778,113.0 | View | |
| Feb 13, 2026 | — | S | D | 425,000.0 | 26.67 | 11,334,750.0 | 15,928,113.0 | View | |
| Feb 13, 2026 | — | S | D | 225,000.0 | 26.5 | 5,962,500.0 | 15,127,329.0 | View | |
| Feb 13, 2026 | — | S | D | 150,784.0 | 26.49 | 3,994,268.16 | 15,352,329.0 | View | |
| Feb 13, 2026 | — | S | D | 275,000.0 | 26.76 | 7,359,000.0 | 15,503,113.0 | View | |
| Feb 13, 2026 | — | S | D | 150,000.0 | 26.72 | 4,008,000.0 | 15,778,113.0 | View | |
| Feb 13, 2026 | — | S | D | 425,000.0 | 26.67 | 11,334,750.0 | 15,928,113.0 | View | |
| Feb 13, 2026 | — | S | D | 225,000.0 | 26.5 | 5,962,500.0 | 15,127,329.0 | View | |
| Feb 13, 2026 | — | S | D | 150,784.0 | 26.49 | 3,994,268.16 | 15,352,329.0 | View | |
| Feb 13, 2026 | — | S | D | 275,000.0 | 26.76 | 7,359,000.0 | 15,503,113.0 | View | |
| Feb 13, 2026 | — | S | D | 150,000.0 | 26.72 | 4,008,000.0 | 15,778,113.0 | View | |
| Feb 13, 2026 | — | S | D | 425,000.0 | 26.67 | 11,334,750.0 | 15,928,113.0 | View | |
| Feb 11, 2026 | President & CIO | M | D | 651,558.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 11, 2026 | President & CIO | J | D | 312,117.0 | 26.47 | 8,261,736.99 | 18,836,547.0 | View | |
| Feb 11, 2026 | President & CIO | S | D | 339,441.0 | 26.47 | 8,985,003.27 | 19,148,664.0 | View | |
| Feb 11, 2026 | President & CIO | M | A | 651,558.0 | 12.68 | 8,261,755.44 | 19,488,105.0 | View | |
| Jan 22, 2026 | — | F | D | 124.0 | 22.98 | 2,849.52 | 119,428.0 | View | |
| Jan 22, 2026 | — | A | A | 1,164.0 | 0.0 | 0.0 | 119,552.0 | View | |
| Jan 22, 2026 | — | F | D | 122.0 | 22.98 | 2,803.56 | 109,030.0 | View | |
| Jan 22, 2026 | — | A | A | 609.0 | 0.0 | 0.0 | 109,152.0 | View | |
| Jan 22, 2026 | — | F | D | 54.0 | 22.98 | 1,240.92 | 57,665.0 | View | |
| Jan 22, 2026 | — | A | A | 815.0 | 0.0 | 0.0 | 57,719.0 | View | |
| Jan 14, 2026 | President & Immunovant CEO | M | D | 200,000.0 | 0.0 | 0.0 | 5,244,834.0 | View | |
| Jan 14, 2026 | President & Immunovant CEO | S | D | 200,000.0 | 21.92 | 4,384,000.0 | 1,654,597.0 | View | |
| Jan 14, 2026 | President & Immunovant CEO | M | A | 200,000.0 | 3.85 | 770,000.0 | 1,854,597.0 | View |